Cargando…

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors

The number of positron-emission tomography (PET) tracers used to evaluate patients with brain tumors has increased substantially over the last years. For the management of patients with brain tumors, the most important indications are the delineation of tumor extent (e.g., for planning of resection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werner, Jan-Michael, Lohmann, Philipp, Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146177/ https://www.ncbi.nlm.nih.gov/pubmed/32213992 http://dx.doi.org/10.3390/molecules25061471

Ejemplares similares

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
por: Wollring, Michael M., et al.
Publicado: (2022)

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

Current status of PET imaging in neuro-oncology
por: Galldiks, Norbert, et al.
Publicado: (2019)

Advances in PET imaging for meningioma patients
por: Galldiks, Norbert, et al.
Publicado: (2023)

Feature-based PET/MRI radiomics in patients with brain tumors
por: Lohmann, Philipp, et al.
Publicado: (2021)

PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)

Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
por: Lohmann, Philipp, et al.
Publicado: (2019)

Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
por: Bauer, Elena Katharina, et al.
Publicado: (2021)

Boosting the acceptance of (18)F-FET PET for image-guided treatment planning with a multi-centric prospective trial
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
por: Lohmann, Philipp, et al.
Publicado: (2019)

Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
por: Galldiks, Norbert, et al.
Publicado: (2016)

Use of advanced neuroimaging and artificial intelligence in meningiomas
por: Galldiks, Norbert, et al.
Publicado: (2022)

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
por: Lohmann, Philipp, et al.
Publicado: (2018)

Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours
por: Lohmann, Philipp, et al.
Publicado: (2014)

Amino acid PET and MR perfusion imaging in brain tumours
por: Filss, Christian P., et al.
Publicado: (2017)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
por: Galldiks, Norbert, et al.
Publicado: (2019)

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
por: Galldiks, Norbert, et al.
Publicado: (2016)

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)

Evaluation of factors influencing (18)F-FET uptake in the brain
por: Verger, Antoine, et al.
Publicado: (2017)

Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
por: Kocher, Martin, et al.
Publicado: (2021)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
por: Friedrich, Michel, et al.
Publicado: (2022)

Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
por: Kocher, Martin, et al.
Publicado: (2021)

32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
por: Galldiks, Norbert, et al.
Publicado: (2020)

Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[(18)F]-fluoroethyl)-l-tyrosine PET
por: Bauer, Elena K., et al.
Publicado: (2020)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

The impact of brain lesions on health-related quality of life in patients with WHO CNS grade 3 or 4 glioma: a lesion-function and resting-state fMRI analysis
por: Heinzel, Alexander, et al.
Publicado: (2023)

Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
por: Galldiks, Norbert, et al.
Publicado: (2009)

Role of the default mode resting-state network for cognitive functioning in malignant glioma patients following multimodal treatment
por: Kocher, Martin, et al.
Publicado: (2020)

(18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection
por: Ort, Jonas, et al.
Publicado: (2021)

Combined (18)F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes
por: D’Amore, Francesco, et al.
Publicado: (2021)

Erratum to: Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
por: Galldiks, Norbert, et al.
Publicado: (2010)

Two Decades of Brain Tumour Imaging with O-(2-[(18)F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience
por: Heinzel, Alexander, et al.
Publicado: (2022)

Applications of radiomics and machine learning for radiotherapy of malignant brain tumors
por: Kocher, Martin, et al.
Publicado: (2020)

Use of PET Imaging in Neuro-Oncological Surgery
por: Holzgreve, Adrien, et al.
Publicado: (2021)

Sequential implementation of DSC-MR perfusion and dynamic [(18)F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
por: Steidl, Eike, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lqfmjk4678dk9tsq55g8d93c0g